AURA
Price
$7.12
Change
+$0.17 (+2.45%)
Updated
Jul 17 closing price
Capitalization
441.47M
20 days until earnings call
BEAM
Price
$20.45
Change
+$0.38 (+1.89%)
Updated
Jul 17 closing price
Capitalization
2.06B
25 days until earnings call
Interact to see
Advertisement

AURA vs BEAM

Header iconAURA vs BEAM Comparison
Open Charts AURA vs BEAMBanner chart's image
Aura Biosciences
Price$7.12
Change+$0.17 (+2.45%)
Volume$176.35K
Capitalization441.47M
Beam Therapeutics
Price$20.45
Change+$0.38 (+1.89%)
Volume$2M
Capitalization2.06B
AURA vs BEAM Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. BEAM commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (AURA: $7.12 vs. BEAM: $20.45)
Brand notoriety: AURA and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 79% vs. BEAM: 102%
Market capitalization -- AURA: $441.47M vs. BEAM: $2.06B
AURA [@Biotechnology] is valued at $441.47M. BEAM’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 6 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 3 bearish.
  • BEAM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а +5.17% price change this week, while BEAM (@Biotechnology) price change was -7.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.06B) has a higher market cap than AURA($441M). AURA YTD gains are higher at: -13.382 vs. BEAM (-17.540). AURA has higher annual earnings (EBITDA): -101.63M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. AURA (128M). AURA has less debt than BEAM: AURA (18.4M) vs BEAM (158M). BEAM has higher revenues than AURA: BEAM (63.6M) vs AURA (0).
AURABEAMAURA / BEAM
Capitalization441M2.06B21%
EBITDA-101.63M-399.03M25%
Gain YTD-13.382-17.54076%
P/E RatioN/AN/A-
Revenue063.6M-
Total Cash128M1.22B10%
Total Debt18.4M158M12%
TECHNICAL ANALYSIS
Technical Analysis
AURABEAM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 25 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SUVZX12.87N/A
N/A
PGIM Quant Solutions Large-Cap Val Z
FMCCX47.09N/A
N/A
Fidelity Advisor Stock Selec Mid Cp I
HWSAX72.87N/A
N/A
Hotchkis & Wiley Small Cap Value A
RGSCX24.10N/A
N/A
Virtus KAR Global Small-Cap C
SSSWX470.35N/A
N/A
State Street Equity 500 Index I